How to afford PrEP and HIV meds if you lose health insurance
There are a variety of free programs that can help people afford medications and care even if they don’t have insurance. Read on for advice from Reina Hernandez, a PrEP benefits and HIV linkage manager from San Francisco
New research finds that 1 in 13 people experienced viral rebound after becoming undetectable, with disparities related to race, housing status, age, and more.
What prevents people from accessing PEP in San Francisco?
Because PEP must be started within 72 hours of an HIV exposure, delays in access can have devastating consequences. A new California law could smooth the way for easier access, but COVID-19 is slowing implementation.
Burning or pain when you pee? It might be the STI mycoplasma genitalium
Magnet clinician Jorge Roman, RN, MSN, FNP-BC, AAHIVS, answers questions about this common STI--including when to get tested and what treatment involves.
For people with HIV, cannabis use linked to lower rates of cognitive impairment
In a study with nearly 1,000 adults, cognitive functions such as verbal fluency, memory, attention and motor skills were significantly less likely to show signs of impairment in people living with HIV who used cannabis.
Charles Hawthorne breaks down how the racist war on drugs stands in the way of health and humanity for drug users, and shares his perspective on reaching people with kindness, empathy and love.
Nuevo informe revela la crisis de VIH en la comunidad latina no reconocida
En “grupos” de transmisión, la transmisión de VIH ocurre a tasas de hasta 33 veces el promedio nacional. Los programas de salud pública y del gobierno deben encontrar maneras de invertir en hacer llegar los servicios de
Unrecognized HIV crisis in Latinx community revealed by new report
In transmission “clusters”, HIV transmission occurs at rates up to 33 times the national average. Public health and government programs must find ways to invest in reaching Latinx communities with HIV services.
In SF, game-changing programs aim to cure all of hepatitis C
New programs in San Francisco are addressing the “silent epidemic” that affects more than 12,000 community members. HCV cure is possible, but many people don’t know it’s an option.
What we know about Descovy’s impact on weight & cholesterol
HIV advocates have raised concerns about the metabolic effects that Descovy (F/TAF) may have on people living with HIV and people taking it for PrEP. Here’s what we know.
